• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Switzerland·Consumer Cyclical·HOCN.SW
Share

HOCHDORF Holding AG Stocks

CHF 1.38Last Updated 26.05.2025

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

CHF 4.34M

CHF 1.38
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

HOCHDORF Holding AG, through its subsidiaries, produces and sells various food products. Its Food Solutions division offers milk, milk protein, whey, fat powder; condensed milk; and cream. The company's Baby Care division provides formula for infants, and follow-on milk for toddlers and pre-school children, as well as milk drinks for pregnant and breast-feeding women; and food for special medical purposes. It primarily sells its products under the HOCHDORF and Bimbosan brands. The company operates in Switzerland, Liechtenstein, rest of Europe, Asia, the Middle East, Africa, the United States, Canada, rest of the Americas, and internationally. HOCHDORF Holding AG was founded in 1895 and is based in Hochdorf, Switzerland.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is 'expensive' on EV/EBITDA, ove

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

30.09.2026 20:26

An investigation in Turkey has affected the assets of the largest sovereign wealth fund, worth $208 million

30.09.2026 19:57

A Calamos fund manager recommends stocks from two small fintech companies. What drew him to them?

30.09.2026 19:27

U.S. Stocks Rise — Slowing Inflation Has Dampened Expectations of a Fed Rate Hike

30.09.2026 19:04

A flydubai pilot tried to deliberately crash a passenger Boeing — Netanyahu

30.09.2026 18:57

AI agents are creating a new market. How can investors profit from it?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026